Use of Anticholinergic Drugs According to Various Criteria and Their Association With Psychological Well-Being and Mortality in Long-Term Care Facilities

Show full item record



Permalink

http://hdl.handle.net/10138/318484

Citation

Aalto , U L , Finne-Soveri , H , Kautiainen , H , Roitto , H-M , Öhman , H & Pitkälä , K H 2019 , ' Use of Anticholinergic Drugs According to Various Criteria and Their Association With Psychological Well-Being and Mortality in Long-Term Care Facilities ' , Journal of the American Medical Directors Association , vol. 20 , no. 9 , pp. 1156-1162 . https://doi.org/10.1016/j.jamda.2019.02.007

Title: Use of Anticholinergic Drugs According to Various Criteria and Their Association With Psychological Well-Being and Mortality in Long-Term Care Facilities
Author: Aalto, Ulla L.; Finne-Soveri, Harriet; Kautiainen, Hannu; Roitto, Hanna-Maria; Öhman, Hannareeta; Pitkälä, Kaisu H.
Contributor organization: Department of General Practice and Primary Health Care
Clinicum
Helsinki University Hospital Area
Teachers' Academy
University of Helsinki
Date: 2019-09
Language: eng
Number of pages: 7
Belongs to series: Journal of the American Medical Directors Association
ISSN: 1525-8610
DOI: https://doi.org/10.1016/j.jamda.2019.02.007
URI: http://hdl.handle.net/10138/318484
Abstract: Objectives: To compare 3 internationally established criteria for drugs with anticholinergic properties (DAPs) and their associated factors in long-term care facilities, and to investigate the association between use of DAPs and psychological well-being (PWB) or mortality. Design: Cross-sectional study and 1-year follow-up of all-cause mortality. Setting and Participants: Of all 4449 residents living in long-term care facilities in Helsinki in 2011, 2432 (>= 65 years of age) participated after exclusion of residents with severe dementia. Measurements: Data on demographics, medication use, and active diagnoses were collected by trained staff using structured questionnaires. DAP use was defined by the following 3 international criteria: Chew's list, the Anticholinergic Risk Scale, and the Anticholinergic Drug Scale. The total number of DAPs was counted and referred to as anticholinergic burden. PWB was assessed by a questionnaire and yielded a score ranging from 0 to 1. Mortality data was retrieved from central registers. Results: Of all participants, 85% were DAP users according to at least 1 of the 3 criteria used. Overlap between the 3 criteria was only moderate. DAP users were younger and a larger proportion of them had better cognition. However, they suffered more often from depression and other psychiatric diagnoses than nonusers. DAP users had lower PWB scores than those not using DAPs, and PWB decreased linearly in the overlapping groups from nonusers to those using DAPs according to all 3 criteria. The total number of DAPs used predicted mortality. Conclusions and Implications: DAP use and PWB appear to be negatively associated. When combining several criteria of DAPs, their burden predicted mortality. Clinicians should carefully consider the potential benefits and harms when prescribing DAPs to older persons. (C) 2019 AMDA - The Society for Post-Acute and Long-Term Care Medicine.
Subject: Anticholinergic drug
anticholinergic burden
aged
psychological well-being
mortality
NURSING-HOME RESIDENTS
QUALITY-OF-LIFE
OLDER-PEOPLE
RISK SCALES
COGNITIVE FUNCTION
BURDEN
MEDICATIONS
DEMENTIA
OUTCOMES
ADULTS
3121 General medicine, internal medicine and other clinical medicine
Peer reviewed: Yes
Rights: cc_by_nc_nd
Usage restriction: openAccess
Self-archived version: acceptedVersion


Files in this item

Total number of downloads: Loading...

Files Size Format View
TUHAT_Use_of_an ... ith_psychological_well.pdf 257.5Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record